Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Define novel modulators of placental drug transport
FY 2009-10
Summary
Multidrug Resistance P-glycoprotein (Mdr1/P-gp) is a protein pump that is important for removing a variety of environmental toxins and drugs from many different types of cells. If Mdr1/P-gp is compromised in these cells, these substances can accumulate inside the cells. In cancer cells, Mdr1/P-gp has shown to be compromised by a group of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) leading to increased accumulation of anticancer drugs. While the effects of SSRI antidepressants are beneficial in cancer cells, it can lead to problems if they have similar effects in other cells. We have previously shown that the SSRI, sertraline, can have significant effects on Mdr1/P-gp mediated drug removal in normal tissues. We have also demonstrated that Mdr1/P-gp is expressed at high levels in the placenta where it prevents harmful substances from entering fetal circulation. Consequently, it is possible these SSRI antidepressants compromise Mdr1/P-gp mediated protection of these substances in the placenta. As 10-15% of women are diagnosed with depression during pregnancy and many are prescribed antidepressants, disruption of this barrier can increase the risk of fetal exposure to many harmful substances. In Aim 1 of the present study, we will determine if SSRIs influence Mdr1/P-gp activity in the mouse placenta, and in doing so, alter drug transfer from mother to fetus. Likewise, it has been shown that infection, via the actions of cytokines, can also act to compromise Mdr1/P-gp in normal tissues. However, the effects of cytokines in the placenta are not well-understood. Since maternal infection is common during pregnancy, it is important to understand how infection changes Mdr1/P-gp function. In Aim 2, we will determine if cytokines influence Mdr1/P-gp activity in the mouse placenta. Understanding the effects of SSRI antidepressants and infection on placental transfer will facilitate the development of innovative strategies for fetal protection.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200994
Name
Bhuiyan Manzerul
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Define novel modulators of placental drug transport
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cytokines; Development; Infection; Mouse Model; Multidrug Resistance; Pcr; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitor; Western Blot
Abstract
Multidrug Resistance P-glycoprotein (Mdr1/P-gp) is a protein pump that is important for removing a variety of environmental toxins and drugs from many different types of cells. If Mdr1/P-gp is compromised in these cells, these substances can accumulate inside the cells. In cancer cells, Mdr1/P-gp has shown to be compromised by a group of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) leading to increased accumulation of anticancer drugs. While the effects of SSRI antidepressants are beneficial in cancer cells, it can lead to problems if they have similar effects in other cells. We have previously shown that the SSRI, sertraline, can have significant effects on Mdr1/P-gp mediated drug removal in normal tissues. We have also demonstrated that Mdr1/P-gp is expressed at high levels in the placenta where it prevents harmful substances from entering fetal circulation. Consequently, it is possible these SSRI antidepressants compromise Mdr1/P-gp mediated protection of these substances in the placenta. As 10-15% of women are diagnosed with depression during pregnancy and many are prescribed antidepressants, disruption of this barrier can increase the risk of fetal exposure to many harmful substances. In Aim 1 of the present study, we will determine if SSRIs influence Mdr1/P-gp activity in the mouse placenta, and in doing so, alter drug transfer from mother to fetus. Likewise, it has been shown that infection, via the actions of cytokines, can also act to compromise Mdr1/P-gp in normal tissues. However, the effects of cytokines in the placenta are not well-understood. Since maternal infection is common during pregnancy, it is important to understand how infection changes Mdr1/P-gp function. In Aim 2, we will determine if cytokines influence Mdr1/P-gp activity in the mouse placenta. Understanding the effects of SSRI antidepressants and infection on placental transfer will facilitate the development of innovative strategies for fetal protection.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bhuiyan, Manzerul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~